FI971777A0 - Katepsiini O2-proteaasi - Google Patents

Katepsiini O2-proteaasi

Info

Publication number
FI971777A0
FI971777A0 FI971777A FI971777A FI971777A0 FI 971777 A0 FI971777 A0 FI 971777A0 FI 971777 A FI971777 A FI 971777A FI 971777 A FI971777 A FI 971777A FI 971777 A0 FI971777 A0 FI 971777A0
Authority
FI
Finland
Prior art keywords
cathepsin
protease
antibodies
proteins
relates
Prior art date
Application number
FI971777A
Other languages
English (en)
Swedish (sv)
Other versions
FI971777A (fi
Inventor
Dieter Broemme
Kathleen Okamoto
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26987129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI971777(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/330,121 external-priority patent/US5736357A/en
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of FI971777A0 publication Critical patent/FI971777A0/fi
Publication of FI971777A publication Critical patent/FI971777A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI971777A 1994-10-27 1997-04-25 Katepsiini O2-proteaasi FI971777A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/330,121 US5736357A (en) 1994-10-27 1994-10-27 Cathespin O protease
US08/536,861 US6544767B1 (en) 1994-10-27 1995-10-02 Cathespin O2 protease
PCT/US1995/013820 WO1996013523A1 (en) 1994-10-27 1995-10-26 Cathepsin o2 protease

Publications (2)

Publication Number Publication Date
FI971777A0 true FI971777A0 (fi) 1997-04-25
FI971777A FI971777A (fi) 1997-04-25

Family

ID=26987129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971777A FI971777A (fi) 1994-10-27 1997-04-25 Katepsiini O2-proteaasi

Country Status (15)

Country Link
US (2) US6544767B1 (fi)
EP (1) EP0783527B1 (fi)
JP (1) JP3670666B2 (fi)
KR (1) KR100473219B1 (fi)
CN (1) CN1148382C (fi)
AT (1) ATE317441T1 (fi)
AU (1) AU711810B2 (fi)
CA (1) CA2203765C (fi)
DE (1) DE69534778T2 (fi)
ES (1) ES2256849T3 (fi)
FI (1) FI971777A (fi)
HU (1) HU220960B1 (fi)
NO (1) NO971875L (fi)
NZ (1) NZ296003A (fi)
WO (1) WO1996013523A1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403304B1 (en) 1993-04-06 2002-06-11 Forsyth Dental Infirmary For Children Human osteoclast-specific and -related DNA sequences
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
PL328877A1 (en) 1995-10-30 1999-03-01 Smithkline Beecham Corp Method of inhibiting cathepsin k
US6586466B2 (en) 1995-10-30 2003-07-01 Smithkline Beecham Corporation Carbohydrazide-protease inhibitors
JP2000500742A (ja) 1995-10-30 2000-01-25 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
EP0812916A3 (en) * 1996-06-14 1998-12-09 Smithkline Beecham Corporation Cathepsin k gene
WO1998000716A1 (en) * 1996-07-03 1998-01-08 Novadx, Inc. Method for detecting degenerative bone disease
GB9701888D0 (en) * 1997-01-30 1997-03-19 Ciba Geigy Ag Novel methods
US5948669A (en) * 1997-02-26 1999-09-07 Smithkline Beecham Corporation Rat cathepsin K polynucleotide and polypeptide sequence
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6346373B1 (en) * 1999-05-05 2002-02-12 Merck Frosst Canada & Co., Whole cell assay for cathepsin K activity
WO2001000798A2 (en) * 1999-06-25 2001-01-04 Hybritech Incorporated Cloning and expressing of human cathepsin k in mammalian cells
AU1474801A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
WO2001053297A1 (en) 2000-01-20 2001-07-26 Merck & Co., Inc. Alpha v integrin receptor antagonists
US7071184B2 (en) 2000-03-21 2006-07-04 Smithkline Beecham Corporation Protease inhibitors
JP2004535153A (ja) * 2000-10-18 2004-11-25 インサイト・ゲノミックス・インコーポレイテッド プロテアーゼ
JP4355287B2 (ja) * 2002-06-17 2009-10-28 株式会社ニチレイ ホッコクアカエビ由来の新規なカテプシンｌ様システインプロテアーゼ
AU2003256305A1 (en) * 2002-06-24 2004-01-06 Axys Pharmaceuticals, Inc. Peptidic compounds as cysteine protease inhibitors
CA2532948A1 (en) * 2003-07-21 2005-02-17 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
US7312353B2 (en) 2003-08-21 2007-12-25 Merck Frost Canada & Co. Cathespin cysteine protease inhibitors
US20070015234A1 (en) * 2003-09-23 2007-01-18 Sylvie Desmarais Whole cell assay for inhibitors of cathepsin k
WO2005093421A1 (de) * 2004-03-10 2005-10-06 Biovendor Laboratory Medicine, Inc. Enzymimmunoassay zur bestimmung von cathepsin k
US7029902B2 (en) * 2004-03-26 2006-04-18 Applera Corporation Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
AU2013202011C1 (en) * 2008-03-06 2015-10-01 Halozyme, Inc. In vivo temporal control of activatable matrix-degrading enzymes
US8901144B2 (en) 2013-02-07 2014-12-02 Scifluor Life Sciences, Llc Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
PT2953948T (pt) 2013-02-07 2017-12-12 Scifluor Life Sciences Inc Antagonistas de integrina fluorada
US10328082B2 (en) 2014-05-30 2019-06-25 Pfizer Inc. Methods of use and combinations
US9790222B2 (en) 2015-02-19 2017-10-17 Scifluor Life Sciences, Inc. Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
WO1997047642A1 (en) 1996-06-14 1997-12-18 Smithkline Beecham Corporation Cathepsin k gene

Also Published As

Publication number Publication date
EP0783527B1 (en) 2006-02-08
DE69534778D1 (en) 2006-04-20
HU220960B1 (hu) 2002-07-29
US6544767B1 (en) 2003-04-08
EP0783527A4 (en) 1998-12-02
CN1170415A (zh) 1998-01-14
WO1996013523A1 (en) 1996-05-09
EP0783527A1 (en) 1997-07-16
ATE317441T1 (de) 2006-02-15
NO971875L (no) 1997-06-12
JP3670666B2 (ja) 2005-07-13
NO971875D0 (no) 1997-04-23
AU711810B2 (en) 1999-10-21
ES2256849T3 (es) 2006-07-16
NZ296003A (en) 1999-10-28
KR970707153A (ko) 1997-12-01
US20030175937A1 (en) 2003-09-18
CA2203765A1 (en) 1996-05-09
DE69534778T2 (de) 2006-08-17
AU3968895A (en) 1996-05-23
CN1148382C (zh) 2004-05-05
CA2203765C (en) 2002-04-23
KR100473219B1 (ko) 2005-05-16
FI971777A (fi) 1997-04-25
JPH10512740A (ja) 1998-12-08
HUT77049A (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
ATE317441T1 (de) Cathepsin-02-protease
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
ES2110386T3 (es) Conjugados de interferon.
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
IL139478A0 (en) Hybrid protein
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE69839444D1 (de) Smad 6 und dessen anwendungen
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
TR199500915A2 (tr) Peptidler.
DE69634077D1 (de) Haemophilus adhäsionsproteinen
SE9602822D0 (sv) New receptor
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
DK0942992T3 (da) O-fucosyltransferase
EP0846165A4 (en) NOVEL PROTEINS AND NUCLEIC ACID MOLECULES OF FILARIID NEMATODE CYSTEIN PROTEASE AND THEIR USE
DE59611293D1 (de) Protein mit dnase-aktivität
NO975534D0 (no) Imidazo-£1,5|-pyridin-avledete serinproteaseinhibitorer
SE9604439D0 (sv) New receptor
ATE283358T1 (de) Protease-ähnliches protein
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
TR199600085A2 (tr) Sismanlamaya karsi proteinler.
MX9203129A (es) Proteinas bmp-5.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.

Legal Events

Date Code Title Description
FD Application lapsed